Allianz Asset Management Gmb H Repligen Corp Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Repligen Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 12,421 shares of RGEN stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,421
Previous 14,653 15.23%
Holding current value
$1.79 Million
Previous $1.85 Million 0.05%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$119.79 - $167.35 $267,371 - $373,525
-2,232 Reduced 15.23%
12,421 $1.85 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $333,960 - $509,149
2,783 Added 23.45%
14,653 $1.85 Million
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $368,543 - $449,770
2,158 Added 22.22%
11,870 $2.18 Million
Q4 2023

Feb 12, 2024
BUY
$114.17 - $185.35 $225,828 - $366,622
1,978 Added 25.58%
9,712 $1.75 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $365,685 - $465,103
2,635 Added 51.68%
7,734 $1.23 Million
Q2 2023

Aug 11, 2023
SELL
$138.42 - $180.31 $1,799 - $2,344
-13 Reduced 0.25%
5,099 $721,000
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $788,577 - $1.01 Million
5,112 New
5,112 $860,000
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $791,043 - $1.06 Million
-5,623 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $159,578 - $255,380
-990 Reduced 14.97%
5,623 $1.06 Million
Q4 2021

Feb 11, 2022
SELL
$247.59 - $304.47 $3.83 Million - $4.72 Million
-15,487 Reduced 70.08%
6,613 $1.75 Million
Q3 2021

Nov 10, 2021
BUY
$194.77 - $324.21 $2.63 Million - $4.38 Million
13,505 Added 157.13%
22,100 $6.39 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $1.08 Million - $1.44 Million
6,535 Added 317.23%
8,595 $1.72 Million
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $3.5 Million - $4.89 Million
-23,660 Reduced 91.99%
2,060 $395,000
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $346,580 - $447,745
-2,829 Reduced 9.91%
25,720 $3.8 Million
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $1.09 Million - $1.63 Million
-11,602 Reduced 28.9%
28,549 $3.53 Million
Q1 2020

May 14, 2020
SELL
$84.96 - $109.14 $390,051 - $501,061
-4,591 Reduced 10.26%
40,151 $3.88 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $391,647 - $493,696
5,304 Added 13.45%
44,742 $4.14 Million
Q3 2019

Nov 13, 2019
BUY
$76.65 - $95.51 $1.68 Million - $2.1 Million
21,979 Added 125.89%
39,438 $3.03 Million
Q2 2019

Aug 08, 2019
BUY
$54.2 - $85.95 $21,571 - $34,208
398 Added 2.33%
17,459 $1.5 Million
Q1 2019

May 13, 2019
BUY
$49.45 - $62.8 $843,666 - $1.07 Million
17,061 New
17,061 $1.01 Million
Q2 2018

Aug 13, 2018
SELL
$35.26 - $47.04 $1.18 Million - $1.57 Million
-33,365 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$30.92 - $37.27 $3.16 Million - $3.81 Million
-102,217 Reduced 75.39%
33,365 $1.21 Million
Q4 2017

Feb 13, 2018
SELL
$32.53 - $38.92 $1.3 Million - $1.55 Million
-39,832 Reduced 22.71%
135,582 $4.92 Million
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $1.55 Million - $1.93 Million
41,842 Added 31.33%
175,414 $6.72 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-16,527 Reduced 11.01%
133,572 $5.54 Million
Q1 2017

Apr 17, 2019
SELL
N/A
-9,273 Reduced 5.82%
150,099 $5.28 Million
Q4 2016

Apr 17, 2019
SELL
N/A
-66,062 Reduced 29.3%
159,372 $4.91 Million
Q3 2016

Apr 17, 2019
BUY
N/A
225,434
225,434 $6.81 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email